Article
New indolylarylsulfone non-nucleoside reverse transcriptase inhibitors show low nanomolar inhibition of single and double HIV-1 mutant strains.
European journal of medicinal chemistry - 15 Dec 2020
Nalli Marianna, Armijos Rivera Jorge I, Masci Domiziana, Coluccia Antonio, Badia Roger, Riveira-Muñoz Eva, Brambilla Alessandro, Cinquina Elisabetta, Turriziani Ombretta, Falasca Francesca, Catalano Myriam, Limatola Cristina, Esté José A, Maga Giovanni, Silvestri Romano, Crespan Emmanuele, La Regina Giuseppe
Abstract excerpt
We designed and synthesized 21 new indolylarylsulfones (IASs) as new HIV-1 NNRTIs. Among these, IAS 12 exhibited a remarkable antiviral activity against single and double mutants (K103N EC50 = <0.7 nM; Y181C EC50 = <0.7 nM; Y188L EC50 = 21.3 nM; K103N-Y181C EC50 = 6.2 nM), resulting equally or more active than previuosly reported IAS 6 and some approved anti-HIV-1 drugs. Docking and molecular dynamics simulations...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
